Yunyi Hong

560 total citations
14 papers, 420 citations indexed

About

Yunyi Hong is a scholar working on Geriatrics and Gerontology, Molecular Biology and Oncology. According to data from OpenAlex, Yunyi Hong has authored 14 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yunyi Hong's work include Sirtuins and Resveratrol in Medicine (9 papers), PARP inhibition in cancer therapy (5 papers) and Autophagy in Disease and Therapy (4 papers). Yunyi Hong is often cited by papers focused on Sirtuins and Resveratrol in Medicine (9 papers), PARP inhibition in cancer therapy (5 papers) and Autophagy in Disease and Therapy (4 papers). Yunyi Hong collaborates with scholars based in China and United States. Yunyi Hong's co-authors include Weihai Ying, Hui Nie, Heyu Chen, Weiliang Xia, Caibin Sheng, Yingxin Ma, Qing Wang, Xin He, Jin Han and Jie Zhang and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Neuroreport.

In The Last Decade

Yunyi Hong

14 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunyi Hong China	11	196	169	113	98	71	14	420
Lucia Cialabrini Italy	7	180 0.9×	204 1.2×	109 1.0×	103 1.1×	66 0.9×	8	497
Brian H. White United States	5	120 0.6×	156 0.9×	88 0.8×	28 0.3×	92 1.3×	8	432
Lucia Polletta Italy	8	176 0.9×	189 1.1×	176 1.6×	55 0.6×	35 0.5×	8	445
John A. Stupinski United States	4	158 0.8×	206 1.2×	85 0.8×	26 0.3×	31 0.4×	10	472
Paride Liscio Italy	8	120 0.6×	259 1.5×	83 0.7×	70 0.7×	114 1.6×	11	543
Marisa W. Friederich United States	16	196 1.0×	589 3.5×	134 1.2×	20 0.2×	29 0.4×	28	879
Jungeun Noh South Korea	7	83 0.4×	181 1.1×	118 1.0×	31 0.3×	17 0.2×	7	349
André Iffland United States	9	163 0.8×	183 1.1×	76 0.7×	44 0.4×	36 0.5×	13	481
Shenzhen Huang China	15	52 0.3×	209 1.2×	30 0.3×	29 0.3×	55 0.8×	39	570
Morten Lundh Denmark	16	43 0.2×	492 2.9×	119 1.1×	48 0.5×	80 1.1×	28	848

Countries citing papers authored by Yunyi Hong

Since Specialization

Citations

This map shows the geographic impact of Yunyi Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunyi Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunyi Hong more than expected).

Fields of papers citing papers by Yunyi Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunyi Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunyi Hong. The network helps show where Yunyi Hong may publish in the future.

Co-authorship network of co-authors of Yunyi Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Yunyi Hong. A scholar is included among the top collaborators of Yunyi Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunyi Hong. Yunyi Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zhang, Jie, Yunyi Hong, Wei Cao, et al.. (2019). SIRT2, ERK and Nrf2 Mediate NAD+ Treatment-Induced Increase in the Antioxidant Capacity of PC12 Cells Under Basal Conditions. Frontiers in Molecular Neuroscience. 12. 108–108. 18 indexed citations

Hong, Yunyi, Hui Nie, Xunbin Wei, Shen Fu, & Weihai Ying. (2015). NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells. Neurochemical Research. 40(4). 837–842. 11 indexed citations

Zhang, Tingting, Tengyuan Liu, Jiaxiang Shao, et al.. (2015). Antioxidant protects blood-testis barrier against synchrotron radiation X-ray-induced disruption. PubMed. 5(1). e1009313–e1009313. 9 indexed citations

Ma, Yingxin, Hui Nie, Heyu Chen, et al.. (2015). NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications. Current Medicinal Chemistry. 22(10). 1239–1247. 36 indexed citations

Lü, Lei, Wenshi Wei, Yunyi Hong, et al.. (2014). Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease. Experimental and Therapeutic Medicine. 8(3). 943–950. 45 indexed citations

Nie, Hui, Yunyi Hong, Xiaofei Lü, et al.. (2014). SIRT2 mediates oxidative stress-induced apoptosis of differentiated PC12 cells. Neuroreport. 25(11). 838–842. 46 indexed citations

Wang, Caixia, Heyu Chen, Jie Zhang, et al.. (2014). Malate-aspartate shuttle mediates the intracellular ATP levels, antioxidation capacity and survival of differentiated PC12 cells.. PubMed. 6(2). 109–14. 10 indexed citations

Hong, Yunyi, Hui Nie, Danhong Wu, et al.. (2013). NAD+ treatment prevents rotenone-induced apoptosis and necrosis of differentiated PC12 cells. Neuroscience Letters. 560. 46–50. 20 indexed citations

Ma, Yingxin, Heyu Chen, Xin He, et al.. (2012). NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases. Current Drug Targets. 13(2). 222–229. 52 indexed citations

10.

Sheng, Caibin, Heyu Chen, Ban Wang, et al.. (2012). NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes.. PubMed. 4(1). 1–9. 14 indexed citations

11.

He, Xin, Hui Nie, Yunyi Hong, et al.. (2011). SIRT2 activity is required for the survival of C6 glioma cells. Biochemical and Biophysical Research Communications. 417(1). 468–472. 63 indexed citations

12.

Nie, Hui, Heyu Chen, Jin Han, et al.. (2011). Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells.. PubMed. 3(1). 65–70. 27 indexed citations

13.

Hong, Yunyi, Jiaxiang Shao, Weiliang Xia, & Weihai Ying. (2010). NAD+ treatment can block rotenone‐induced nuclear apoptotic changes of PC12 cells. The FASEB Journal. 24(S1). 2 indexed citations

14.

Xia, Weiliang, Zheng Wang, Qing Wang, et al.. (2009). Roles of NAD / NADH and NADP+ / NADPH in Cell Death. Current Pharmaceutical Design. 15(1). 12–19. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact